Charles Schwab’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,000
| Closed | -$70K | – | 3591 |
|
|
2022
Q3 | $70K | Sell |
58,000
-515,476
| -90% | -$804K | ﹤0.01% | 3264 |
|
|
2022
Q2 | $1.03M | Sell |
573,476
-354,766
| -38% | -$523K | ﹤0.01% | 2781 |
|
|
2022
Q1 | $1.88M | Buy |
928,242
+76,620
| +9% | +$151K | ﹤0.01% | 2665 |
|
|
2021
Q4 | $2.31M | Buy |
851,622
+105,553
| +14% | +$390K | ﹤0.01% | 2658 |
|
|
2021
Q3 | $3.33M | Buy |
746,069
+42,824
| +6% | +$206K | ﹤0.01% | 2564 |
|
|
2021
Q2 | $4.08M | Buy |
703,245
+38,911
| +6% | +$228K | ﹤0.01% | 2444 |
|
|
2021
Q1 | $4.66M | Buy |
664,334
+90,535
| +16% | +$607K | ﹤0.01% | 2336 |
|
|
2020
Q4 | $2.75M | Sell |
573,799
-387
| -0.1% | -$1.96K | ﹤0.01% | 2501 |
|
|
2020
Q3 | $3.35M | Buy |
574,186
+19,434
| +4% | +$116K | ﹤0.01% | 2273 |
|
|
2020
Q2 | $3.75M | Buy |
554,752
+145,997
| +36% | +$1.11M | ﹤0.01% | 2162 |
|
|
2020
Q1 | $2.6M | Buy |
408,755
+92,221
| +29% | +$740K | ﹤0.01% | 2159 |
|
|
2019
Q4 | $3.3M | Buy |
316,534
+6,083
| +2% | +$44.2K | ﹤0.01% | 2230 |
|
|
2019
Q3 | $1.22M | Buy |
310,451
+9,006
| +3% | +$72.8K | ﹤0.01% | 2515 |
|
|
2019
Q2 | $4.48M | Buy |
301,445
+10,217
| +4% | +$185K | ﹤0.01% | 2028 |
|
|
2019
Q1 | $7.23M | Buy |
291,228
+13,632
| +5% | +$342K | ﹤0.01% | 1777 |
|
|
2018
Q4 | $4.99M | Sell |
277,596
-2,032
| -0.7% | -$41.5K | ﹤0.01% | 1904 |
|
|
2018
Q3 | $8.21M | Buy |
279,628
+14,702
| +6% | +$569K | 0.01% | 1766 |
|
|
2018
Q2 | $12M | Buy |
264,926
+35,192
| +15% | +$1.71M | 0.01% | 1464 |
|
|
2018
Q1 | $12.1M | Buy |
229,734
+8,810
| +4% | +$514K | 0.01% | 1358 |
|
|
2017
Q4 | $15M | Buy |
220,924
+11,030
| +5% | +$771K | 0.01% | 1192 |
|
|
2017
Q3 | $17.3M | Buy |
209,894
+20,267
| +11% | +$1.61M | 0.02% | 1039 |
|
|
2017
Q2 | $17.8M | Buy |
189,627
+14,961
| +9% | +$915K | 0.02% | 953 |
|
|
2017
Q1 | $11.1M | Buy |
174,666
+30,623
| +21% | +$1.86M | 0.01% | 1242 |
|
|
2016
Q4 | $6.4M | Buy |
144,043
+8,307
| +6% | +$292K | 0.01% | 1573 |
|
|
2016
Q3 | $4.89M | Buy |
135,736
+30,550
| +29% | +$655K | 0.01% | 1665 |
|
|
2016
Q2 | $1.44M | Buy |
105,186
+3,444
| +3% | +$50.3K | ﹤0.01% | 2214 |
|
|
2016
Q1 | $1.95M | Buy |
101,742
+3,745
| +4% | +$79.3K | ﹤0.01% | 2062 |
|
|
2015
Q4 | $3.43M | Buy |
97,997
+2,797
| +3% | +$180K | ﹤0.01% | 1759 |
|
|
2015
Q3 | $8.76M | Buy |
95,200
+11,106
| +13% | +$961K | 0.01% | 1084 |
|
|
2015
Q2 | $7.39M | Buy |
84,094
+2,777
| +3% | +$238K | 0.01% | 1268 |
|
|
2015
Q1 | $6.04M | Buy |
81,317
+4,105
| +5% | +$290K | 0.01% | 1379 |
|
|
2014
Q4 | $4.32M | Buy |
77,212
+2,864
| +4% | +$151K | 0.01% | 1548 |
|
|
2014
Q3 | $3.37M | Buy |
74,348
+5,233
| +8% | +$219K | 0.01% | 1660 |
|
|
2014
Q2 | $2.86M | Buy |
69,115
+9,954
| +17% | +$513K | ﹤0.01% | 1772 |
|
|
2014
Q1 | $4.1M | Buy |
59,161
+2,037
| +4% | +$150K | 0.01% | 1490 |
|
|
2013
Q4 | $3.44M | Buy |
57,124
+13,181
| +30% | +$717K | 0.01% | 1557 |
|
|
2013
Q3 | $2.73M | Buy |
43,943
+4,172
| +10% | +$296K | 0.01% | 1652 |
|
|
2013
Q2 | $2.77M | Buy |
+39,771
| New | +$1.79M | 0.01% | 1533 |
|
Other funds holding CLVS
IA
CAS
CASC
STB
MCM
WS
FFWM
NFSG
